transurethral resection of bladder tumor

transurethral resection of bladder tumor

Resection of small low-grade noninvasive papillary transitional cell carcinomas of the urinary bladder with a cystoscope
Mentioned in ?
References in periodicals archive ?
Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system.
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
Specimens were obtained from cystoscopic biopsy in 11 cases, transurethral resection of bladder tumor in 4 cases, radical cystectomy or cystoprostatectomy in 6 cases, and periureteral and common iliac lymph node with associated soft tissue resection in 1 case.
The Phase 1 study is required by the local regulatory authorities and is designed to enroll up to 6 patients and determine the safety and pharmacokinetics of an immediate instillation of apaziquone in the bladder following transurethral resection of bladder tumor (TURBT), followed by 6 weekly instillations of apaziquone in the bladder, starting week 4.
The Phase 2b study was a multicenter, single-arm, open-label safety study with the objective of assessing the effect on surgical wound healing and systemic absorption of EOquin when given intravesically as a single dose immediately after transurethral resection of bladder tumor (TUR-BT).

Full browser ?